Can cetuximab affect paraneoplastic myopathy?
J Neurooncol
; 93(3): 437-8, 2009 Jul.
Article
en En
| MEDLINE
| ID: mdl-19159079
ABSTRACT
Cetuximab given concurrently with chemotherapy has shown survival benefit for patients with metastatic colon cancer. We report a case of a patient with metastatic colon cancer who developed paraneoplastic necrotizing myopathy that possibly responded to cetuximab despite lack of improvement of the underlying cancer.
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Síndromes Paraneoplásicos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Anticuerpos Monoclonales
/
Enfermedades Musculares
Tipo de estudio:
Etiology_studies
Idioma:
En
Revista:
J Neurooncol
Año:
2009
Tipo del documento:
Article
País de afiliación:
Grecia